- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05219825
Breathwork-assisted Treatment for Cannabis Use Disorder
February 1, 2024 updated by: Elias Dakwar
Breathwork-assisted Treatment for Cannabis Use Disorder: A Proof-of-concept Study
The purpose of this proof-of-concept study is to evaluate the safety, feasibility and acceptability of a breathwork workshop intervention in individuals with cannabis use disorder.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This study will test a 1-week breathwork workshop for treatment-seeking adults with a diagnosis of cannabis use disorder.
The intervention consists of an enhanced breathing session with evocative music to facilitate experiencing non-ordinary states of consciousness, in addition to brief therapeutic interventions based on Motivational Interviewing and Mindfulness-based Relapse Prevention (MBRP).
The primary aim is to test the acceptability, feasibility and safety of enhanced breathwork in a therapeutic framework for cannabis use disorder.
In addition, the investigators seek to understand the phenomenology of breathwork that may explain any change related to addictive behaviors, as well as biological changes that occur during the breathwork session through heart rate variability and electroencephalography.
Study Type
Interventional
Enrollment (Estimated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Danielle Mayall, B.A
- Phone Number: (888) 497-8427
- Email: danielle.mayall@nyspi.columbia.edu
Study Contact Backup
- Name: Silvia J Franco Corso, M.D
- Phone Number: (914) 481-3820
- Email: silvia.franco-corso@nyspi.columbia.edu
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Recruiting
- New York State Psychiatric Institute
-
Contact:
- Silvia Franco Corso, M.D.
- Email: silvia.franco-corso@nyspi.columbia.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 18-70 years of age
- Meets Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria for active cannabis use disorder.
- Seeking treatment for their cannabis use
Exclusion Criteria:
- Meets DSM-V criteria for schizophrenia or any psychotic illness or any dissociative disorder (Dissociative identity disorder, Dissociative amnesia, Depersonalization/derealization disorder).
- Active substance use disorder except for cannabis, nicotine, and caffeine.
- History of severe withdrawal symptoms (i.e withdrawal seizures).
- History of dementia, epilepsy or seizures, cardiac arrhythmia, pacemaker/defibrillator, heart failure, asthma, panic disorder and other respiratory illnesses (ie: COPD).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Breathwork group
Treatment-seeking individuals with cannabis use disorder who will participate in the 1-week breathwork workshop.
|
Participants will complete 1.5 hours of breathwork session in addition to a total of 6 hours of brief psychotherapeutic intervention in a span of 1 week.
The therapy sessions will occur both before and after the breathing session.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acceptability of the breathwork session
Time Frame: One week after the breathing session.
|
Acceptability of the breathwork intervention through self-reported questionnaires.
|
One week after the breathing session.
|
Safety of the breathing session
Time Frame: 24 hours after the breathing session.
|
Occurrence of adverse effects through a self-reported questionnaire.
|
24 hours after the breathing session.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Cue Reactivity
Time Frame: From baseline to 1 month after the breathing session.
|
Serial visual analogue scale for craving elicited by cannabis use.
|
From baseline to 1 month after the breathing session.
|
Change in Motivation to Quit
Time Frame: From baseline to 1 month after the breathing session.
|
Measured with the "Stages of Change Readiness and Treatment Eagerness Scale."
|
From baseline to 1 month after the breathing session.
|
Change in cannabis use
Time Frame: From baseline to 1 month after the breathing session.
|
Changes in cannabis use as measured by the Timeline Followback.
|
From baseline to 1 month after the breathing session.
|
Phenomenology of breathwork #1
Time Frame: 24 hours after the breathing session
|
Subjective experiences during the breathing session will be assessed with the 30-item Mystical Experience Questionnaire.
|
24 hours after the breathing session
|
Phenomenology of breathwork #2
Time Frame: Obtained 24 hours after the breathing session
|
Subjective experiences during the breathing session will be assessed with the Emotional Breakthrough Inventory.
|
Obtained 24 hours after the breathing session
|
Heart Rate Variability
Time Frame: Measured during breathing session
|
Polar (H10) chest strap
|
Measured during breathing session
|
Electroencephalographic changes
Time Frame: Measured during breathing session
|
Electroencephalograpy cap
|
Measured during breathing session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Silvia J Franco Corso, M.D, New York State Psychiatric Institute/ Columbia University Medical Center
- Study Chair: Elias Dakwar, M.D, New York State Psychiatric Institute/ Columbia University Medical Center
- Study Director: Kate O'Malley, M.A, New York State Psychiatric Institute/ Columbia University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 6, 2022
Primary Completion (Estimated)
August 1, 2024
Study Completion (Estimated)
August 1, 2024
Study Registration Dates
First Submitted
December 30, 2021
First Submitted That Met QC Criteria
February 1, 2022
First Posted (Actual)
February 2, 2022
Study Record Updates
Last Update Posted (Actual)
February 2, 2024
Last Update Submitted That Met QC Criteria
February 1, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 8165
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Addiction
-
The Hong Kong Polytechnic UniversityRecruiting
-
City University of Hong KongCompletedQuality of Life | Psychological Distress | Internet Gaming Disorder | Social Media Addiction | Smartphone AddictionChina
-
Gazi UniversityRecruitingAddiction | Physical Inactivity | Social Media AddictionTurkey
-
Daegu Catholic University Medical CenterCompletedInternet AddictionKorea, Republic of
-
The Hong Kong Polytechnic UniversityRecruitingPrevalence of Internet Addiction and it's Effects on Psychological Well-being of Adults in Hong KongInternet AddictionHong Kong
-
Dr. Wang Man-PingActive, not recruiting
-
Mustafa YumusakCumhuriyet UniversityNot yet recruitingSmartphone Addiction | Students, NursingTurkey
-
Kutahya Health Sciences UniversityCompletedMental Fatigue | Smartphone AddictionTurkey
-
Bar-Ilan University, IsraelRecruitingInfant Behavior | Breastfeeding | Mother-Infant Interaction | Smartphone AddictionIsrael
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedSmartphone Users, Smartphone Addiction, Anxiety, and Skin ConductanceTaiwan
Clinical Trials on Breathwork workshop
-
University of California, San DiegoNot yet recruitingHypoxic Breathwork With Music and Affirmative Messaging | Hypoxic Breathwork Only | Music and Affirmative Messaging
-
Richard BlakeCompleted
-
University of SussexUniversity of California, San Francisco; Brighton & Sussex Medical School; Sylff...CompletedStress | Anxiety | Depressive Symptoms | Positive Affect | Sleep-Related Impairment | Mental Wellbeing | Negative AffectUnited Kingdom
-
Instituto de Investigación Sanitaria de la Fundación...Recruiting
-
University of WaterlooActive, not recruitingPsychological DistressCanada
-
Johns Hopkins Bloomberg School of Public HealthNational Institute on Drug Abuse (NIDA)CompletedDepression | HIV | Drug UseUnited States
-
Observatoire Regional de la Sante Provence-Alpes-Côte...University of Bordeaux; University of Avignon; Institut National de Recherche... and other collaboratorsCompletedNutrition, HealthyFrance
-
University of ArizonaCompletedStress | Stress, Psychological | Stress Reaction | Adjustment | Adjustment, Emotional | Adjustment, Social
-
University Hospital, AngersUnknownAlzheimer Disease | Impaired Cognition | Gait ApraxiaFrance